Aspirin Dosing for Elderly Patients with Cardiovascular Disease History

Introduction to Aspirin Dosing

The American College of Cardiology recommends aspirin 75-100 mg daily for lifelong secondary prevention in elderly patients with established cardiovascular disease, with a strength of evidence based on high-quality trials 1

For patients with coronary artery disease, the American Heart Association recommends aspirin 75-162 mg daily, unless contraindicated, with a strength of evidence based on high-quality trials 2, 3
After percutaneous coronary intervention, the American Heart Association suggests 81 mg daily as a reasonable and preferred maintenance dose to reduce bleeding risk while maintaining efficacy, with a strength of evidence based on high-quality trials 2, 3
For symptomatic peripheral artery disease, the American College of Cardiology recommends aspirin 75-325 mg daily, with a strength of evidence based on high-quality trials 4, 5, 6
The European Society of Cardiology guidelines specify aspirin 75-160 mg once daily as the preferred range for peripheral artery disease, with a strength of evidence based on high-quality trials 7
For patients with cerebrovascular disease, the American Heart Association recommends aspirin 75-325 mg daily, with a strength of evidence based on high-quality trials 2, 3

Elderly patients face substantially higher bleeding risk with aspirin, with major bleeding events occurring at approximately 5 per 1,000 per year, according to the American College of Cardiology, with a strength of evidence based on observational studies 1
The American College of Cardiology suggests using the lowest effective dose (75-81 mg) to reduce bleeding complications while maintaining cardiovascular efficacy, with a strength of evidence based on high-quality trials 1

After acute coronary syndrome or stent placement, the American College of Cardiology recommends dual antiplatelet therapy with aspirin and a P2Y12 inhibitor for at least 12 months, with a strength of evidence based on high-quality trials 2, 3
For patients with a compelling indication for anticoagulation, the American Heart Association suggests administering warfarin in addition to low-dose aspirin 75-81 mg daily, with a strength of evidence based on high-quality trials 2, 3
The European Society of Cardiology recommends combination rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily for patients with peripheral artery disease at high ischemic risk and non-high bleeding risk, with a strength of evidence based on high-quality trials 7

The American College of Cardiology recommends confirming established cardiovascular disease and assessing bleeding risk factors before initiating aspirin therapy, with a strength of evidence based on expert opinion 1
For patients with low-moderate bleeding risk, the American College of Cardiology suggests starting aspirin 75-81 mg daily, with a strength of evidence based on high-quality trials 1
For patients with high bleeding risk but established cardiovascular disease, the American College of Cardiology recommends considering clopidogrel 75 mg daily as an alternative, with a strength of evidence based on high-quality trials 2, 3, 1